You are here

Newsroom

Top News

Press Release | January 13, 2017
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement today regarding CMS’s ruling that certain continuous glucose monitors (CGMs) approved by FDA for making diabetes treatment decisions are considered durable medical equipment and are eligible to be covered by Medicare:
Press Release | January 12, 2017
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on introduction of bipartisan legislation in the U.S. Senate to permanently repeal the medical device excise tax:
Press Release | January 10, 2017
WASHINGTON, D.C. – Medical technology companies are leveraging the 2015 suspension of the medical device excise tax to expand their businesses and investments, according to a new survey from the Advanced Medical Technology Association (AdvaMed).